These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23439433)

  • 1. PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition.
    Conte E; Gili E; Fruciano M; Korfei M; Fagone E; Iemmolo M; Lo Furno D; Giuffrida R; Crimi N; Guenther A; Vancheri C
    Lab Invest; 2013 May; 93(5):566-76. PubMed ID: 23439433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms.
    Conte E; Fruciano M; Fagone E; Gili E; Caraci F; Iemmolo M; Crimi N; Vancheri C
    PLoS One; 2011; 6(10):e24663. PubMed ID: 21984893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis.
    Watts KL; Cottrell E; Hoban PR; Spiteri MA
    Respir Res; 2006 Jun; 7(1):88. PubMed ID: 16776827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase D is increased and activated in lung epithelial cells and macrophages in idiopathic pulmonary fibrosis.
    Gan H; McKenzie R; Hao Q; Idell S; Tang H
    PLoS One; 2014; 9(7):e101983. PubMed ID: 25000413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPP1 induces idiopathic pulmonary fibrosis and NSCLC progression via the PI3K/Akt/mTOR pathway.
    Yue B; Xiong D; Chen J; Yang X; Zhao J; Shao J; Wei D; Gao F; Huang M; Chen J
    Respir Res; 2024 Oct; 25(1):362. PubMed ID: 39369217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.
    Amara N; Goven D; Prost F; Muloway R; Crestani B; Boczkowski J
    Thorax; 2010 Aug; 65(8):733-8. PubMed ID: 20685750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor paracrine upregulation in idiopathic pulmonary fibrosis fibroblasts is blocked by nintedanib.
    Epstein Shochet G; Brook E; Eyal O; Edelstein E; Shitrit D
    Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1025-L1034. PubMed ID: 30810067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.
    Leppäranta O; Pulkkinen V; Koli K; Vähätalo R; Salmenkivi K; Kinnula VL; Heikinheimo M; Myllärniemi M
    Am J Respir Cell Mol Biol; 2010 May; 42(5):626-32. PubMed ID: 19597127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
    Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
    J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis.
    MacKenzie B; Korfei M; Henneke I; Sibinska Z; Tian X; Hezel S; Dilai S; Wasnick R; Schneider B; Wilhelm J; El Agha E; Klepetko W; Seeger W; Schermuly R; Günther A; Bellusci S
    Respir Res; 2015 Jul; 16(1):83. PubMed ID: 26138239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC8 inhibition ameliorates pulmonary fibrosis.
    Saito S; Zhuang Y; Suzuki T; Ota Y; Bateman ME; Alkhatib AL; Morris GF; Lasky JA
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L175-L186. PubMed ID: 30358439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro.
    Joannes A; Brayer S; Besnard V; Marchal-Sommé J; Jaillet M; Mordant P; Mal H; Borie R; Crestani B; Mailleux AA
    Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L615-29. PubMed ID: 26773067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.
    Bamberg A; Redente EF; Groshong SD; Tuder RM; Cool CD; Keith RC; Edelman BL; Black BP; Cosgrove GP; Wynes MW; Curran-Everett D; De Langhe S; Ortiz LA; Thorburn A; Riches DWH
    Am J Respir Crit Care Med; 2018 Oct; 198(7):914-927. PubMed ID: 29727583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 16. Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis.
    Geng J; Huang X; Li Y; Xu X; Li S; Jiang D; Liang J; Jiang D; Wang C; Dai H
    Respir Res; 2015 Oct; 16():124. PubMed ID: 26453058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
    Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
    Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.
    Bartis D; Crowley LE; D'Souza VK; Borthwick L; Fisher AJ; Croft AP; Pongrácz JE; Thompson R; Langman G; Buckley CD; Thickett DR
    BMC Pulm Med; 2016 Apr; 16(1):51. PubMed ID: 27080864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia induces pulmonary fibroblast proliferation through NFAT signaling.
    Senavirathna LK; Huang C; Yang X; Munteanu MC; Sathiaseelan R; Xu D; Henke CA; Liu L
    Sci Rep; 2018 Feb; 8(1):2709. PubMed ID: 29426911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
    Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
    BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.